Literature DB >> 24917584

In vitro activity of mecillinam against Enterobacteriaceae with NDM-1 carbapenemase.

Emma C L Marrs1, Kathryn M Day1, John D Perry2.   

Abstract

Entities:  

Keywords:  antimicrobial susceptibility; urinary tract infections; β-lactamases

Mesh：

Substances：

Year:  2014        PMID： 24917584     DOI： 10.1093/jac/dku204

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  8 in total

1.  In Vivo Evolution of CTX-M-215, a Novel Narrow-Spectrum β-Lactamase in an Escherichia coli Clinical Isolate Conferring Resistance to Mecillinam.

Authors:  Minggui Wang; Qinglan Guo; Mengyun Yin; Guoping Hu; Zhen Shen; Chengli Fang; Xuefei Zhang; Dan Li; Yohei Doi; Yu Zhang
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

2.  Activity of temocillin, mecillinam, ceftazidime, and ceftazidime/avibactam against carbapenem-non-susceptible Enterobacteriaceae without carbapenemase production.

Authors:  N T Mutters; S Zimmermann; M Kaase; A Mischnik
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-10-03       Impact factor: 3.267

3.  Results from a Prospective In Vitro Study on the Mecillinam (Amdinocillin) Susceptibility of Enterobacterales.

Authors:  Frieder Fuchs; Axel Hamprecht
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

4.  Activity of mecillinam against carbapenem-resistant Enterobacterales.

Authors:  Cécile Emeraud; Alexandre Godmer; Delphine Girlich; Océane Vanparis; Fériel Mahamdi; Elodie Creton; Agnès B Jousset; Thierry Naas; Rémy A Bonnin; Laurent Dortet
Journal:  J Antimicrob Chemother       Date:  2022-09-30       Impact factor: 5.758

5.  Resistance to Mecillinam and Nine Other Antibiotics for Oral Use in Escherichia coli Isolated from Urine Specimens of Primary Care Patients in Germany, 2019/20.

Authors:  Michael Kresken; Yvonne Pfeifer; Florian Wagenlehner; Guido Werner; Esther Wohlfarth; On Behalf Of Study Group 'Antimicrobial Resistance' Of The Paul Ehrlich Society For Infection Therapy
Journal:  Antibiotics (Basel)       Date:  2022-05-31

Review 6.  NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings.

Authors:  Wenjing Wu; Yu Feng; Guangmin Tang; Fu Qiao; Alan McNally; Zhiyong Zong
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

7.  Molecular and epidemiological characterization of carbapenemase-producing Enterobacteriaceae in Norway, 2007 to 2014.

Authors:  Ørjan Samuelsen; Søren Overballe-Petersen; Jørgen Vildershøj Bjørnholt; Sylvain Brisse; Michel Doumith; Neil Woodford; Katie L Hopkins; Bettina Aasnæs; Bjørg Haldorsen; Arnfinn Sundsfjord
Journal:  PLoS One       Date:  2017-11-15       Impact factor: 3.240

8.  Susceptibility of Clinical Enterobacterales Isolates With Common and Rare Carbapenemases to Mecillinam.

Authors:  Frieder Fuchs; Aysel Ahmadzada; Lars Plambeck; Thorsten Wille; Axel Hamprecht
Journal:  Front Microbiol       Date:  2021-01-12       Impact factor: 5.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.